B. Anderson

A Phase I/II Trial of Xcellerated T Cells™ in Patients with Chronic Lymphocytic Leukemia.

T. Kipps, M. Keating, W. Wierda, 2004 .

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor GX15-070 Administered Intravenously (IV) Every 3 Weeks to Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL).

B. Cheson, T. Kipps, M. Keating, 2005 .

Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial

David M. Liebovitz, Tejas Mehta, D. Boulware, 2023, medRxiv.